Verastem Inc. Stock
Price
Target price
€8.60
€8.60
-2.300%
-0.2
-2.300%
€27.03
25.04.24 / Tradegate
WKN: A3EHM3 / Symbol: VSTM / Name: Verastem / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Verastem Inc. Stock
We can see a decrease in the price for Verastem Inc.. Compared to yesterday it has lost -€0.200 (-2.300%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Verastem Inc..
Based on the current price of 8.6 € the target price of 27 € shows a potential of 213.95% for Verastem Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Verastem Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Verastem Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Verastem Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Verastem Inc. | -2.300% | -10.417% | -19.626% | 109.185% | 13.907% | -69.109% | - |
| Ardelyx Inc. | -2.390% | -2.578% | -17.883% | 40.048% | 2.007% | -13.927% | - |
| Salarius Pharmaceuticals Inc. | -3.170% | -2.727% | -46.500% | -69.209% | -22.883% | -98.244% | -99.994% |
| Brainstorm Cell | 1.170% | 3.754% | -21.032% | -81.975% | 114.440% | -80.717% | - |
Comments
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $27.00 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
